Vertex Pharmaceuticals (VRTX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
483.88
3.55 (0.74%)
At close: Feb 21, 2025, 3:17 PM
Vertex Pharmaceuticals Revenue
Vertex Pharmaceuticals reported an annual revenue of $11.02B, reflecting a 11.66% growth. For the quarter ending December 31, 2024, Vertex Pharmaceuticals generated $2.91B in revenue.
Revenue (ttm)
$11.02B
Revenue Growth
11.66%
Price / Sales Ratio
9.41
Revenue / Employee
$1.81M
Employees
6,100
Market Cap
124.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
2024-12-31 | 11.02B | +11.66% |
2023-12-31 | 9.87B | +10.51% |
2022-12-31 | 8.93B | +17.91% |
2021-12-31 | 7.57B | +22.06% |
2020-12-31 | 6.21B | n/a |